Yep. 4 patients treated....
The logical conclusion is that R327 doesn't work, on burns at least.
It is incredible that RCE haven't updated the market about the outcome.
They saw fit to release a very positive market sensitive update about the trial in Dec 2021:
https://hotcopper.com.au/threads/ann-update-on-phase-i-ii-clinical-trial-for-burn-wound-infection.6471068/
Therefore, surely bad news about the trial is also market sensitive?
Surely it's important to update shareholders that RCEs one and only trial in a CLINICAL population has ended in abandonment?
It's incredible the SP has not taken a beating. Mkt cap of $125m?! Surely people are not actually fooled by this meaningless SAS nonsense and some pretty pictures?!
What the dickens is going on?!
(20min delay)